Tag: privacy concern

November 9, 2021

How new digital methods can increase atopic dermatitis screener completions and enrollment

Difficulties in atopic dermatitis patient recruitment is one of the biggest causes of clinical trial delays: 40% of atopic dermatitis studies experience delays due to poor patient retention, while 30% of study terminations are due to enrollment issues. New digital screening techniques, developed by Clariness, can in part help solve these issues and boost both the number of screener completions and enrollment rates.

In this blog, we explore the growing competition for eligible patients with atopic dermatitis, how digital methods are the future of patient screenings, and about Clariness’ innovative handprint Body Surface Area (BSA) screener that helps patients more accurately self-identify their affected BSA.

November 9, 2021

How to leverage data to boost atopic dermatitis trial registrations

Difficulties in atopic dermatitis patient recruitment is one of the biggest causes of clinical trial delays: 40% of atopic dermatitis studies experience delays due to poor patient retention, while 30% of study terminations are due to enrollment issues. New digital screening techniques, developed by Clariness, can in part help solve these issues and boost both the number of screener completions and enrollment rates.

In this blog, we explore the growing competition for eligible patients with atopic dermatitis, how digital methods are the future of patient screenings, and about Clariness’ innovative handprint Body Surface Area (BSA) screener that helps patients more accurately self-identify their affected BSA.

November 9, 2021

How to address patient privacy and data-security concerns in clinical trials

Difficulties in atopic dermatitis patient recruitment is one of the biggest causes of clinical trial delays: 40% of atopic dermatitis studies experience delays due to poor patient retention, while 30% of study terminations are due to enrollment issues. New digital screening techniques, developed by Clariness, can in part help solve these issues and boost both the number of screener completions and enrollment rates.

In this blog, we explore the growing competition for eligible patients with atopic dermatitis, how digital methods are the future of patient screenings, and about Clariness’ innovative handprint Body Surface Area (BSA) screener that helps patients more accurately self-identify their affected BSA.